Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia

Article Abstract:

Tailoring chemotherapy to a child's metabolic rate may improve prognosis in children with certain types of acute lymphoblastic leukemia. Children metabolize drugs differently and those who metabolize drugs quickly may not benefit as well from chemotherapy. Researchers randomly assigned 182 children with acute lymphoblastic leukemia to receive chemotherapy based on their body surface area or on their metabolic rate. Tailoring the drug dosage to the metabolic rate improved prognosis, but only in children with leukemia of the B cell line.

Author: Pui, Ching-Hon, Relling, Mary V., Evans, William E., Boyett, James M., Rodman, John H., Crom, William R.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1998
Health aspects, Dosage and administration, Chemotherapy, Drug metabolism, Lymphoblastic leukemia in children, Childhood leukemia

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Acute lymphoblastic leukemia

Article Abstract:

Researchers continue to look for promising treatments for acute lymphoblastic leukemia. This form of leukemia usually strikes children and cure rates are almost 80%. Adults have a poorer prognosis, with cure rates around 30% to 40%. Treatment consists of multi-drug chemotherapy. Stem cell transplants and gene therapy are two possible options. Many patients also have metabolic abnormalities that need to be corrected. Various factors can be used to classify patients at high, average, or low risk of relapsing.

Author: Pui, Ching-Hon, Evans, William E.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1998
Analysis, Lymphocytic leukemia

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Treatment of acute lymphoblastic leukemia

Article Abstract:

The latest advances in the treatment of acute lymphoblastic leukemia (ALL) are described, emphasizing issues that must be addressed if treatment outcome is to improve further. Age and leukocyte count at diagnosis continue to be strong prognostic indicators of outcome, mainly among patients with B-cell precursor ALL.

Author: Evans, William E., Ching-Hon Pui
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2006
United States, Care and treatment, Diagnosis, Prognosis

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Acute lymphocytic leukemia
Similar abstracts:
  • Abstracts: A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. Adjuvant therapy for pancreatic cancer-the debate continues
  • Abstracts: Pharmacogenetic characteristics of indinavir, zidovudine, and lamivudine therapy in HIV-infected adults: A pilot study
  • Abstracts: No phenotype associated with established lipopolysaccharide model for cerebral palsy. Postnatal inflammatory rat model for cerebral palsy: Too different from humans
  • Abstracts: Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
  • Abstracts: Teaching students to question. Pregnancy outcomes before and after a diagnosis of systemic lupus erythematosus
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.